ABT vs OTLK · P/E 25, rev $44.33B vs P/E 0.4, rev $1.5M
Abbott Laboratories (ABT) versus OUTLOOK THERAPEUTICS INC (OTLK) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
OUTLOOK THERAPEUTICS INC (OTLK) is a biotechnology company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported OTLK revenue for 2025-06-30 was $1.5M. Net income was -$20.2M. OTLK currently screens at market cap $68.6M and trailing P/E 0.4.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. OTLK currently screens at market cap $68.6M and trailing P/E 0.4.
Not investment advice. Open the ABT and OTLK stock pages for the full models.
Not investment advice.